251 related articles for article (PubMed ID: 27506682)
1. Risk of End-Stage Liver Disease in HIV-Viral Hepatitis Coinfected Persons in North America From the Early to Modern Antiretroviral Therapy Eras.
Klein MB; Althoff KN; Jing Y; Lau B; Kitahata M; Lo Re V; Kirk GD; Hull M; Kim HN; Sebastiani G; Moodie EE; Silverberg MJ; Sterling TR; Thorne JE; Cescon A; Napravnik S; Eron J; Gill MJ; Justice A; Peters MG; Goedert JJ; Mayor A; Thio CL; Cachay ER; Moore R; ;
Clin Infect Dis; 2016 Nov; 63(9):1160-1167. PubMed ID: 27506682
[TBL] [Abstract][Full Text] [Related]
2. Trends in Hepatocellular Carcinoma Incidence and Risk Among Persons With HIV in the US and Canada, 1996-2015.
Sun J; Althoff KN; Jing Y; Horberg MA; Buchacz K; Gill MJ; Justice AC; Rabkin CS; Goedert JJ; Sigel K; Cachay E; Park L; Lim JK; Kim HN; Lo Re V; Moore R; Sterling T; Peters MG; Achenbach CJ; Silverberg M; Thorne JE; Mayor AM; Crane HM; Kitahata MM; Klein M; Kirk GD;
JAMA Netw Open; 2021 Feb; 4(2):e2037512. PubMed ID: 33595662
[TBL] [Abstract][Full Text] [Related]
3. Liver decompensation in HIV/Hepatitis B coinfection in the combination antiretroviral therapy era does not seem increased compared to hepatitis B mono-infection.
Lieveld FI; Smit C; Richter C; van Erpecum KJ; Spanier BWM; Gisolf EH; Vrolijk JM; Siersema PD; Hoepelman AIM; Reiss P; Arends JE
Liver Int; 2019 Mar; 39(3):470-483. PubMed ID: 30411848
[TBL] [Abstract][Full Text] [Related]
4. Hepatotoxicity and effectiveness of a Nevirapine-based antiretroviral therapy in HIV-infected patients with or without viral hepatitis B or C infection in Cameroon.
Mbougua JB; Laurent C; Kouanfack C; Bourgeois A; Ciaffi L; Calmy A; Gwet H; Koulla-Shiro S; Ducos J; Mpoudi-Ngolé E; Molinari N; Delaporte E
BMC Public Health; 2010 Mar; 10():105. PubMed ID: 20193053
[TBL] [Abstract][Full Text] [Related]
5. Determinants of Liver Complications Among HIV/Hepatitis B Virus-Coinfected Patients.
Lo Re V; Newcomb CW; Carbonari DM; Roy JA; Althoff KN; Kitahata MM; Reddy KR; Lim JK; Silverberg MJ; Mayor AM; Horberg MA; Cachay ER; Kirk GD; Hull M; Gill J; Sterling TR; Kostman JR; Peters MG; Moore RD; Klein MB; Kim HN;
J Acquir Immune Defic Syndr; 2019 Sep; 82(1):71-80. PubMed ID: 31107304
[TBL] [Abstract][Full Text] [Related]
6. End-stage liver disease: prevalence, risk factors and clinical characteristics in a cohort of HIV-HCV coinfected Han Chinese.
Deng L; Gui X; Xiong Y; Gao S; Yang R; Rong Y; Hu J; Yan Y
Clin Res Hepatol Gastroenterol; 2012 Dec; 36(6):574-82. PubMed ID: 22481087
[TBL] [Abstract][Full Text] [Related]
7. Modeling the impact of early antiretroviral therapy for adults coinfected with HIV and hepatitis B or C in South Africa.
Martin NK; Devine A; Eaton JW; Miners A; Hallett TB; Foster GR; Dore GJ; Easterbrook PJ; Legood R; Vickerman P
AIDS; 2014 Jan; 28 Suppl 1():S35-46. PubMed ID: 24468945
[TBL] [Abstract][Full Text] [Related]
8. Opportunistic disease and mortality in patients coinfected with hepatitis B or C virus in the strategic management of antiretroviral therapy (SMART) study.
Tedaldi E; Peters L; Neuhaus J; Puoti M; Rockstroh J; Klein MB; Dore GJ; Mocroft A; Soriano V; Clotet B; Lundgren JD;
Clin Infect Dis; 2008 Dec; 47(11):1468-75. PubMed ID: 18959492
[TBL] [Abstract][Full Text] [Related]
9. Relationship of liver disease stage and antiviral therapy with liver-related events and death in adults coinfected with HIV/HCV.
Limketkai BN; Mehta SH; Sutcliffe CG; Higgins YM; Torbenson MS; Brinkley SC; Moore RD; Thomas DL; Sulkowski MS
JAMA; 2012 Jul; 308(4):370-8. PubMed ID: 22820790
[TBL] [Abstract][Full Text] [Related]
10. Coinfection with hepatitis viruses and outcome of initial antiretroviral regimens in previously naive HIV-infected subjects.
De Luca A; Bugarini R; Lepri AC; Puoti M; Girardi E; Antinori A; Poggio A; Pagano G; Tositti G; Cadeo G; Macor A; Toti M; D'Arminio Monforte A;
Arch Intern Med; 2002 Oct; 162(18):2125-32. PubMed ID: 12374521
[TBL] [Abstract][Full Text] [Related]
11. Seroprevalence of hepatitis B virus (HBV) and hepatitis C virus (HCV) among human immunodeficiency virus (HIV)-infected patients in an HBV endemic area in Brazil.
da Silva CM; de Peder LD; Guelere AM; Horvath JD; Silva ES; Teixeira JJV; Bertolini DA
PLoS One; 2018; 13(9):e0203272. PubMed ID: 30192795
[TBL] [Abstract][Full Text] [Related]
12. Clinical outcomes of liver transplantation in human immunodeficiency virus/hepatitis B virus coinfected patients in China.
Tang J; Weng R; Fang T; Zhang K; Yan X; Jin X; Xie L; Zhao D
BMC Infect Dis; 2024 Apr; 24(1):383. PubMed ID: 38589801
[TBL] [Abstract][Full Text] [Related]
13. Safety profile of maraviroc in patients coinfected with HIV-1 and hepatitis B or C included in the maraviroc expanded access program.
Lazzarin A; Than S; Valluri SR; Heera J; Mukwaya G
HIV Clin Trials; 2012; 13(2):83-9. PubMed ID: 22510355
[TBL] [Abstract][Full Text] [Related]
14. Increased risk of hip fracture associated with dually treated HIV/hepatitis B virus coinfection.
Byrne DD; Newcomb CW; Carbonari DM; Nezamzadeh MS; Leidl KB; Herlim M; Yang YX; Hennessy S; Kostman JR; Leonard MB; Localio AR; Lo Re V
J Viral Hepat; 2015 Nov; 22(11):936-47. PubMed ID: 25754215
[TBL] [Abstract][Full Text] [Related]
15. Combination Antiretroviral Therapy Is Associated With Reduction in Liver Fibrosis Scores in HIV-1-Infected Subjects.
Li Y; Xie J; Han Y; Wang H; Lv W; Guo F; Qiu Z; Li Y; Du S; Song X; Zhu T; Thio CL; Li T
Medicine (Baltimore); 2016 Feb; 95(5):e2660. PubMed ID: 26844493
[TBL] [Abstract][Full Text] [Related]
16. The role of HIV/hepatitis B virus/hepatitis C virus RNA+ triple infection in end-stage liver disease and all-cause mortality in Europe.
Mocroft A; Geressu A; Beguelin C; Llibre JM; Lazarus JV; Tomazic J; Smidt J; Parczewski M; Brännström J; Sedlacek D; Degen O; van der Valk M; Paduta D; Flamholc L; Schmid P; Orkin C; Nielsen LN; Hoffmann C; Beniowski M; Oprea C; Begovac J; Peters L
AIDS; 2023 Jan; 37(1):91-103. PubMed ID: 36476454
[TBL] [Abstract][Full Text] [Related]
17. Hepatic safety and tolerability of raltegravir among HIV patients coinfected with hepatitis B and/or C.
Hurt CB; Napravnik S; Moore RD; Eron JJ
Antivir Ther; 2014; 19(4):415-22. PubMed ID: 24458137
[TBL] [Abstract][Full Text] [Related]
18. Impact and management of hepatitis B and hepatitis C virus co-infection in HIV patients.
Kumar R; Singla V; Kacharya Sk
Trop Gastroenterol; 2008; 29(3):136-47. PubMed ID: 19115605
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B viremia in HIV-coinfected individuals under antiretroviral therapy.
Weissmann L; Picone CM; Gouvêa MSG; Ferreira PRA; Viana MSVB; Pinho JRR; Cassenote AJF; Segurado AC
Braz J Infect Dis; 2019; 23(6):441-450. PubMed ID: 31715124
[TBL] [Abstract][Full Text] [Related]
20. Clinical outcomes of hepatitis B virus coinfection in a United States cohort of hepatitis C virus-infected patients.
Kruse RL; Kramer JR; Tyson GL; Duan Z; Chen L; El-Serag HB; Kanwal F
Hepatology; 2014 Dec; 60(6):1871-8. PubMed ID: 25065513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
